Novel highly selective peroxisome proliferator-activated receptor delta (PPAR delta) modulators with pharmacokinetic properties suitable for once-daily oral dosing.
Lagu, B., Kluge, A.F., Fredenburg, R.A., Tozzo, E., Senaiar, R.S., Jaleel, M., Panigrahi, S.K., Tiwari, N.K., Krishnamurthy, N.R., Takahashi, T., Patane, M.A.(2017) Bioorg Med Chem Lett 27: 5230-5234
- PubMed: 29103972 
- DOI: https://doi.org/10.1016/j.bmcl.2017.10.037
- Primary Citation of Related Structures:  
5XMX - PubMed Abstract: 
Optimization of benzamide PPARδ modulator 1 led to (E)-6-(2-((4-(furan-2-yl)-N-methylbenzamido)methyl)phenoxy)-4-methylhex-4-enoic acid (18), a potent selective PPARδ modulator with significantly improved exposure in multiple species following oral administration.
Organizational Affiliation: 
Mitobridge, Inc., 1030 Massachusetts Ave., Cambridge, MA 02138, United States. Electronic address: blagu@mitobridge.com.